SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002368
Filing Date
2020-04-16
Accepted
2020-04-16 17:28:25
Documents
4
Period of Report
2020-05-28
Effectiveness Date
2020-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241314zdef14a.htm DEF 14A 363944
2 G494085.JPG g494085.jpg GRAPHIC 22452
3 G21042BGI001.GIF g21042bgi001.gif GRAPHIC 108248
4 G21042BGI002.GIF g21042bgi002.gif GRAPHIC 73224
  Complete submission text file 0001047469-20-002368.txt   646343
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 20797203
SIC: 2834 Pharmaceutical Preparations